-- Days : -- HRS : -- MIN : -- SEC

Register Now →

News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Opinion|Videos|August 20, 2024

Patient Education, Provider Education, and Overall Final Thoughts

Author(s)Brian Keegan, MD, PhD, Giselle Mosnaim, MD, Stanley Goldstein, MD

In this discussion, panelists offer their final thoughts.

Episodes in this series

A panel of 4 experts on chronic spontaneous urticaria

EP. 1 The Pathophysiology of Chronic Spontaneous Urticaria

A panel of 4 experts on chronic spontaneous urticaria

EP. 2 Hallmark Symptoms of Chronic Spontaneous Urticaria

A panel of 4 experts on chronic spontaneous urticaria

EP. 3 The Epidemiology Associated With Chronic Spontaneous Urticaria 

A panel of 4 experts on chronic spontaneous urticaria

EP. 4 Differential Diagnosis When Considering Chronic Spontaneous Urticaria 

A panel of 4 experts on chronic spontaneous urticaria

EP. 5 Healthcare Specialties Involved in Managing Patients With Chronic Spontaneous Urticaria 

A panel of 4 experts on chronic spontaneous urticaria

EP. 6 Therapies Typically Used in the Firstline For Patients With Chronic Spontaneous Urticaria 

A panel of 4 experts on chronic spontaneous urticaria

EP. 7 Approaches to Switching Between Antihistamines and Other Medications When Treating Patients with Chronic Spontaneous Urticaria 

A panel of 4 experts on chronic spontaneous urticaria

EP. 8 The Use of Systemic Corticosteroids In Chronic Spontaneous Urticaria Treatment

A panel of 4 experts on chronic spontaneous urticaria

EP. 9 Addressing Persistent Symptoms in Chronic Spontaneous Urticaria: Beyond IgE-Targeted Treatments

A panel of 4 experts on chronic spontaneous urticaria

EP. 10 Key Updates Needed in Chronic Spontaneous Urticaria Guidelines

A panel of 4 experts on chronic spontaneous urticaria

EP. 11 The Evaluation of Dupilumab In Chronic Spontaneous Urticaria Treatment

A panel of 4 experts on chronic spontaneous urticaria

EP. 12 Navigating New Frontiers: Bruton Tyrosine Kinase Inhibitors in Chronic Spontaneous Urticaria Treatment

A panel of 4 experts on chronic spontaneous urticaria

EP. 13 Patient Education, Provider Education, and Overall Final Thoughts

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Pediatric skin irritation | Image Credit: © Ari-stock.adobe.com

Pediatric Chronic Skin Disorders Linked to Poorer Mental Health

August 3rd 2026

hand eczema | Image credit: Ольга Тернавская - stock.adobe.com

Delgocitinib Cream Projected to Save US Health Plans $87.8M Over 3 Years in Hand Eczema

BySkylar Jeremias

July 28th 2026

Reimbursement Erosion Reshapes Dermatology: Jane Grant-Kels, MD, FAAD

ByHabiba Atta,Jane M. Grant-Kels, MD, FAAD

July 25th 2026

Prior authorization button on a computer keyboard | Image credit: AliFuat - stock.adobe.com

Dermatology Practices Absorb Rising Prior Authorization Costs

ByLaura Joszt, MA

July 23rd 2026

Closing Dermatology's Rural Workforce Gaps: Jane Grant-Kels, MD

ByHabiba Atta,Jane M. Grant-Kels, MD, FAAD

July 21st 2026

Trending on AJMC

High-Dose Vitamin D3 Fails to Improve PFS in Phase 3 Metastatic CRC Trial

OneOncology Partners With OpenEvidence to Give Physicians Access Within Clinical Workflows

FDA Approves Moderna’s mRNA Flu Vaccine After Phase 3 Success

After Wild Ride, FDA Grants Accelerated Approval for Replimune’s RP1 Plus Nivolumab in Advanced Melanoma

Patients With MASLD Had More Than 2 Times Higher Odds of Eosinophilic Esophagitis Across Age Groups